MGNK — Mologen AG Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- €0.06m
- -€2.76m
- €3.05m
Annual cashflow statement for Mologen AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
C2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -17.1 | -20.5 | -21 | -19.3 | -11.9 |
Depreciation | |||||
Non-Cash Items | 0.894 | 0.534 | 0.198 | 0.241 | 0.173 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.447 | 4.79 | 1.15 | -0.131 | -2.01 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -15.6 | -15.1 | -19.3 | -19.1 | -13.7 |
Capital Expenditures | -0.093 | -0.095 | -0.057 | -0.033 | -0.01 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 6.02 | 0.003 | 0.013 | 0.039 | 0.001 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 5.93 | -0.092 | -0.044 | 0.006 | -0.009 |
Financing Cash Flow Items | 0 | 0 | -0.018 | -0.326 | -0.448 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 14.5 | 26.2 | 15.2 | 5.13 | 15.2 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 4.8 | 11 | -4.07 | -14 | 1.5 |